- Home
- ASRV vs MRSN Comparison
ASRV vs MRSN Comparison
Compare ASRV & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRV
- MRSN
- Stock Information
- Founded
- ASRV 1983
- MRSN 2001
- Country
- ASRV United States
- MRSN United States
- Employees
- ASRV N/A
- MRSN N/A
- Industry
- ASRV Major Banks
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- ASRV Finance
- MRSN Health Care
- Exchange
- ASRV Nasdaq
- MRSN Nasdaq
- Market Cap
- ASRV 40.1M
- MRSN 40.7M
- IPO Year
- ASRV N/A
- MRSN 2017
- Fundamental
- Price
- ASRV $2.81
- MRSN $0.34
- Analyst Decision
- ASRV
- MRSN Strong Buy
- Analyst Count
- ASRV 0
- MRSN 5
- Target Price
- ASRV N/A
- MRSN $5.75
- AVG Volume (30 Days)
- ASRV 21.7K
- MRSN 3.0M
- Earning Date
- ASRV 07-15-2025
- MRSN 05-15-2025
- Dividend Yield
- ASRV 4.30%
- MRSN N/A
- EPS Growth
- ASRV N/A
- MRSN N/A
- EPS
- ASRV 0.22
- MRSN N/A
- Revenue
- ASRV $53,037,000.00
- MRSN $34,006,000.00
- Revenue This Year
- ASRV N/A
- MRSN N/A
- Revenue Next Year
- ASRV N/A
- MRSN N/A
- P/E Ratio
- ASRV $12.97
- MRSN N/A
- Revenue Growth
- ASRV 16.87
- MRSN N/A
- 52 Week Low
- ASRV $2.03
- MRSN $0.26
- 52 Week High
- ASRV $3.06
- MRSN $2.83
- Technical
- Relative Strength Index (RSI)
- ASRV 79.00
- MRSN 46.86
- Support Level
- ASRV $2.64
- MRSN $0.34
- Resistance Level
- ASRV $2.67
- MRSN $0.38
- Average True Range (ATR)
- ASRV 0.10
- MRSN 0.04
- MACD
- ASRV 0.03
- MRSN 0.00
- Stochastic Oscillator
- ASRV 97.46
- MRSN 33.64
About ASRV AmeriServ Financial Inc.
AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.